<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01131130</url>
  </required_header>
  <id_info>
    <org_study_id>655</org_study_id>
    <nct_id>NCT01131130</nct_id>
  </id_info>
  <brief_title>Feasibility of a New Silicone Hydrogel Lens</brief_title>
  <official_title>A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the product feasibility of the investigational
      contact lens (Test) when compared to the currently marketed Acuvue Oasys contact lens
      (Control) and the Air Optix Aqua contact lens (Control) when worn by adapted wearers of soft
      contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort Throughout the Day - Test Lens vs. Air Optix Aqua Lens</measure>
    <time_frame>7 days</time_frame>
    <description>Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort Throughout the Day - Test Lens vs. Acuvue Oasys</measure>
    <time_frame>7 days</time_frame>
    <description>Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lens Wettability, Test Lens vs. Acuvue Oasys</measure>
    <time_frame>7 days</time_frame>
    <description>Lens wettability was assessed at each visit as Grade 4 - 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas &gt; 0.5 mm in size).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lens Wettability, Test Lens vs. Air Optix Aqua</measure>
    <time_frame>7 days</time_frame>
    <description>Lens wettability was assessed at each visit as Grade 4 - 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas &gt; 0.5 mm in size).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Investigational contact lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bausch &amp; Lomb</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acuvue Oasys Contact Lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Johnson &amp; Johnson Lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air Optix Aqua</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciba Vision</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational contact lens</intervention_name>
    <description>After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
    <arm_group_label>Investigational contact lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acuvue Oasys Contact Lens</intervention_name>
    <description>After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
    <arm_group_label>Acuvue Oasys Contact Lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Air Optix Aqua</intervention_name>
    <description>After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
    <arm_group_label>Air Optix Aqua</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants must have clear central corneas and be free of any anterior segment
             disorders.

          -  Participants must be adapted wearers of soft contact lenses, wear a lens in each eye,
             and each lens must be of the same manufacture and brand.

          -  Participants must be myopic and require lens correction from -0.75 D to - 4.75D in
             each eye.

        Exclusion Criteria:

          -  Participants who have worn gas permeable (GP) contact lenses within the last 30 days
             or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.

          -  Participants with any systemic disease affecting ocular health.

          -  Participants using any systemic or topical medications that will, in the
             Investigator's opinion, affect ocular physiology or lens performance.

          -  Participants with an active ocular disease or are using any ocular medication.

          -  Participants who have had any corneal surgery (eg, refractive surgery).

          -  Participants who are allergic to any component in the study care products.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard Carains, MCOptom, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2010</study_first_submitted>
  <study_first_submitted_qc>May 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2010</study_first_posted>
  <results_first_submitted>March 28, 2014</results_first_submitted>
  <results_first_submitted_qc>March 28, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 30, 2014</results_first_posted>
  <last_update_submitted>March 28, 2014</last_update_submitted>
  <last_update_submitted_qc>March 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact lens</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>There were 120 participants enrolled in this bilateral eye, three-period crossover study at four investigative sites in the United States (US). All participants were adapted wearers of soft contact lenses. The first participant was enrolled in the study on 5/10/2010 and the last participant exited the study on 6/10/2010.</recruitment_details>
      <pre_assignment_details>Participants were equally randomized to one of six treatment sequences of the investigational RD2106 contact lens (Test), the Air Optix Aqua contact lens, and the Acuvue Oasys contact lens. Of the 120 participants enrolled 2 were ineligible at baseline and 2 discontinued following dispensing of lenses. 116 participants completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Over All Study</title>
          <description>Participants were equally randomized to one of six treatment sequences of the investigational RD2106 contact lens (Test), the Air Optix Aqua contact lens, and the Acuvue Oasys contact lens. Crossover occurred following 1 week of lens wear. The 6 groups were as follows Test, Air Optix Aqua, Acuvue Oasys; Test, Acuvue Oasys, Air Optix Aqua; Air Optix Aqua, Test, Acuvue Oasys; Air Optix Aqua, Acuvue Oasys, Test; Acuvue Oasys, Test, Air Optix Aqua; Acuvue Oasys, Air Optix Aqua, Test.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1 - Baseline</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="118"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="117">Participant was discontinued 1 day following dispensing and not reported in result tables</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2 - Crossover</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 3- Crossover</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="116"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>+ Slit lamp finding</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All eligible, dispensed participants</population>
      <group_list>
        <group group_id="B1">
          <title>Over All Study</title>
          <description>Participants were equally randomized to one of six treatment sequences of the investigational RD2106 contact lens (Test), the Air Optix Aqua contact lens, and the Acuvue Oasys contact lens. Crossover occurred following 1 week of lens wear. The 6 groups were as follows Test, Air Optix Aqua, Acuvue Oasys; Test, Acuvue Oasys, Air Optix Aqua; Air Optix Aqua, Test, Acuvue Oasys; Air Optix Aqua, Acuvue Oasys, Test; Acuvue Oasys, Test, Air Optix Aqua; Acuvue Oasys, Air Optix Aqua, Test.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="117"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.3" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Lens Wettability, Test Lens vs. Acuvue Oasys</title>
        <description>Lens wettability was assessed at each visit as Grade 4 – 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas &gt; 0.5 mm in size).</description>
        <time_frame>7 days</time_frame>
        <population>All eligible, dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Contact Lens</title>
            <description>Bausch &amp; Lomb
Investigational contact lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
          <group group_id="O2">
            <title>Acuvue Oasys Contact Lens</title>
            <description>Johnson &amp; Johnson Lens
Acuvue Oasys Contact Lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Wettability, Test Lens vs. Acuvue Oasys</title>
          <description>Lens wettability was assessed at each visit as Grade 4 – 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas &gt; 0.5 mm in size).</description>
          <population>All eligible, dispensed eyes</population>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="232"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Optimal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="210"/>
                    <measurement group_id="O2" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort Throughout the Day - Test Lens vs. Air Optix Aqua Lens</title>
        <description>Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.</description>
        <time_frame>7 days</time_frame>
        <population>All eligible dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Contact Lens</title>
            <description>Bausch &amp; Lomb
Investigational contact lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua</title>
            <description>Ciba Vision
Air Optix Aqua: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Throughout the Day - Test Lens vs. Air Optix Aqua Lens</title>
          <description>Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.</description>
          <population>All eligible dispensed eyes</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="230"/>
                <count group_id="O2" value="232"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.3" spread="22.1"/>
                    <measurement group_id="O2" value="79.4" spread="22.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort Throughout the Day - Test Lens vs. Acuvue Oasys</title>
        <description>Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.</description>
        <time_frame>7 days</time_frame>
        <population>All eligible, dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Contact Lens</title>
            <description>Bausch &amp; Lomb
Investigational contact lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
          <group group_id="O2">
            <title>Acuvue Oasys Contact Lens</title>
            <description>Johnson &amp; Johnson Lens
Acuvue Oasys Contact Lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Throughout the Day - Test Lens vs. Acuvue Oasys</title>
          <description>Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.</description>
          <population>All eligible, dispensed eyes</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="230"/>
                <count group_id="O2" value="232"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.3" spread="22.1"/>
                    <measurement group_id="O2" value="88.0" spread="22.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lens Wettability, Test Lens vs. Air Optix Aqua</title>
        <description>Lens wettability was assessed at each visit as Grade 4 – 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas &gt; 0.5 mm in size).</description>
        <time_frame>7 days</time_frame>
        <population>All eligible, dispensed eyes</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Contact Lens</title>
            <description>Bausch &amp; Lomb
Investigational contact lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
          <group group_id="O2">
            <title>Air Optix Aqua</title>
            <description>Ciba Vision
Air Optix Aqua: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Wettability, Test Lens vs. Air Optix Aqua</title>
          <description>Lens wettability was assessed at each visit as Grade 4 – 0, with 4=optimal (100% of anterior surface wettable) and 0=severe (Presence of one or more non-wetting areas &gt; 0.5 mm in size).</description>
          <population>All eligible, dispensed eyes</population>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="231"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Optimal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="210"/>
                    <measurement group_id="O2" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Slight</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 Days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Investigational Contact Lens</title>
          <description>Bausch &amp; Lomb
Investigational contact lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
        </group>
        <group group_id="E2">
          <title>Acuvue Oasys Contact Lens</title>
          <description>Johnson &amp; Johnson Lens
Acuvue Oasys Contact Lens: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
        </group>
        <group group_id="E3">
          <title>Air Optix Aqua</title>
          <description>Ciba Vision
Air Optix Aqua: After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="117"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="117"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Robert Steffen</name_or_title>
      <organization>Bausch + Lomb</organization>
      <phone>585-338-6399</phone>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

